Condition: Ovarian Stimulation · Sponsor: ART Fertility Clinics LLC
This study examines if monitoring serum Follicle Stimulation Hormone (FSH) levels can predict oocyte yield and progesterone levels, considering factors like age, baseline FSH, Antral Mullerian Hormone (AMH), antral follicle count, body weight, kidney function, and urinary FSH. The aim is to find a minimum FSH level that ensures optimal ovarian response and enables tailored FSH dosages for better outcomes.
This description comes directly from the study's public registry record.
Jonalyn Edades · +971526408688 · jonalyn.edades@artfertilityclinics.com
Baris Ata, MD · +971504374824 · baris.ata@artfertilityclinics.com
Always discuss trial participation with your own doctor first.
| ART Fertility Clinics | Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06572930